Pharmaceutical Business Review
The milestone increases Jeito’s assets under management to 1.6bn, following the 534m closure of Jeito I in 2021.
Pharmaceutical Business Review
The milestone increases Jeito's assets under management to 1.6bn, following the 534m closure of Jeito I in 2021.
Pharmaceutical Business Review
The milestone increases Jeito’s assets under management to 1.6bn, following the 534m closure of Jeito I in 2021.